Title |
Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9)
|
---|---|
Published in |
Basic Research in Cardiology, January 2015
|
DOI | 10.1007/s00395-015-0463-z |
Pubmed ID | |
Authors |
Rainer Schulz, Klaus-Dieter Schlüter, Ulrich Laufs |
Abstract |
The proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as a promising treatment target to lower serum cholesterol, a major risk factor of cardiovascular diseases. Gain-of-function mutations of PCSK9 are associated with hypercholesterolemia and increased risk of cardiovascular events. Conversely, loss-of-function mutations cause low-plasma LDL-C levels and a reduction of cardiovascular risk without known unwanted effects on individual health. Experimental studies have revealed that PCSK9 reduces the hepatic uptake of LDL-C by increasing the endosomal and lysosomal degradation of LDL receptors (LDLR). A number of clinical studies have demonstrated that inhibition of PCSK9 alone and in addition to statins potently reduces serum LDL-C concentrations. This review summarizes the current data on the regulation of PCSK9, its molecular function in lipid homeostasis and the emerging evidence on the extra-hepatic effects of PCSK9. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Argentina | 1 | 33% |
United States | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Scientists | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 2 | 1% |
Russia | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 180 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 32 | 17% |
Student > Ph. D. Student | 28 | 15% |
Student > Master | 23 | 13% |
Student > Bachelor | 23 | 13% |
Student > Postgraduate | 8 | 4% |
Other | 30 | 16% |
Unknown | 40 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 45 | 24% |
Biochemistry, Genetics and Molecular Biology | 32 | 17% |
Agricultural and Biological Sciences | 21 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 12 | 7% |
Chemistry | 5 | 3% |
Other | 14 | 8% |
Unknown | 55 | 30% |